Conduction Disease After Transcatheter Aortic Valve Replacement

NACompletedINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

July 16, 2020

Primary Completion Date

February 17, 2022

Study Completion Date

August 1, 2022

Conditions
Aortic StenosisHeart BlockAortic Insufficiency
Interventions
DIAGNOSTIC_TEST

Electrophysiology Study

After informed consent is obtained, patient will undergo TAVR as per usual standard of care. Using the same femoral vein access as is used standard for a portion of the TAVR procedure, an EPS will be performed during the TAVR procedure, immediately before and after valve implantation. The patient will recover on a general telemetry floor as per usual care, and the next day will undergo another EPS. This is not uncommonly done clinically for some patients after TAVR. At that point, based on the baseline EKG, intra-procedure findings, and EPS findings, the patient will either have a pacemaker implanted, a 30-day event monitor ordered, or neither of the above.

Trial Locations (1)

48202

Henry Ford Health System, Detroit

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Medtronic

INDUSTRY

lead

Henry Ford Health System

OTHER